MS-275
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MS-275, covering 2010-03-10 to 2017-04-17. Get the full timeline:
Most recent: Clinical Trial Update: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [Phase 2]